NCSM presents a paradoxical profile: it is fundamentally undervalued with a Graham Number of $98.24 and a low P/E of 8.03, yet it carries a weak Piotroski F-Score of 3/9, indicating deteriorating financial health trends. While the balance sheet is exceptionally clean with a Debt/Equity ratio of 0.09 and high liquidity, the sharp increase in Forward P/E (24.21) suggests a significant expected contraction in earnings. Explosive recent earnings growth is offset by bearish insider sentiment and a very weak technical trend (10/100). The stock is a value play with high volatility and concerning momentum signals.